Public signalCompany raiseAuto-indexed · Unverified

Oric Pharmaceuticals, Inc. raised $125.0M

Oric Pharmaceuticals, Inc.· SOUTH SAN FRANCISCO, US· Biotechnology· Filed Jun 6, 2025

Oric Pharmaceuticals, Inc. reported raising capital. Based in SOUTH SAN FRANCISCO, CALIFORNIA, US. First sale reported 2025-05-29. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$125.0M
Confidence90%
Raised
$125.0M
Investors
15
Jurisdiction
DELAWARE

On the record

Location
SOUTH SAN FRANCISCO, US
Sector
Biotechnology
Record type
Company raise
Stage
Reported raised
Amount raised
$125.0M
Target amount
$125.0M
Filing date
Jun 6, 2025
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Industry group
Biotechnology
Number of investors
15
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$125.0M
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 125,000,000 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Jun 6, 2025. Details beyond the filing have not been verified.

Tags

USCompanyBiotechnologyOver $100MCompany Raise

Are you associated with Oric Pharmaceuticals, Inc.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record